国内电商巨头阿里巴巴集团近日宣称，由于政府政策变化，已暂停旗下天猫平台的网上售药业务。
Chinese e-commerce giant Alibaba Group has ceased online sales of medicines on its Tmall platform, citing changes in government regulation.
天猫收到了河北省食品药品监督管理局的通知，要求对药品类目采取紧急管控措施。
Tmall has received a notice from the China Food and Drug Administration's (CFDA) Hebei province branch, requiring "urgent control measures relating to drug products".
天猫在声明中表示，将配合停止第三方平台药品网上零售业务。
Tmall said in a statement it will cooperate and stop the online medicine retail business on the third-party platform.
由于越来越多的电商企业计划进军非处方药网上销售市场，这一新规的出台颇为出人意料。食品药品监督管理局目前也并没有详细说明为什么药物销售被叫停。
The new regulations come as a surprise as an increasing number of e-commerce companies plan to tap into the online sales of over-the-counter medicines. The CFDA did not elaborate on the reason why sales were halted.
一位拒绝透露姓名的有业内人士表示，这一规定并不只适用于天猫。
An industrial insider, who refused to be named, said the regulation did not only apply to Tmall.
从事第三方平台药品网上零售的其他电商企业，比如一号店，也将收到当地食药监局的类似通知。
Other e-commerce companiesinvolved in selling drugs on third-party platforms, such as Yhd.com, are expected to receive similar orders from local food and drug authorities.